Prey for the Proteasome: Targeted Protein Degradation-A Medicinal Chemist's Perspective

被引:117
作者
Luh, Laura M. [1 ]
Scheib, Ulrike [1 ]
Juenemann, Katrin [1 ]
Wortmann, Lars [1 ]
Brands, Michael [1 ]
Cromm, Philipp M. [1 ]
机构
[1] Bayer AG, Pharmaceut, Res & Dev, D-13353 Berlin, Germany
关键词
chemical biology; medicinal chemistry; molecular glue; PROTACs; targeted protein degradation; SMALL-MOLECULE PROTACS; HEAT-INDUCIBLE DEGRON; E3 UBIQUITIN LIGASES; SPATIOTEMPORAL CONTROL; ANDROGEN RECEPTOR; DRUG DISCOVERY; PROTEOLYSIS; RECOGNITION; STABILITY; SYSTEM;
D O I
10.1002/anie.202004310
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Targeted protein degradation (TPD), the ability to control a proteins fate by triggering its degradation in a highly selective and effective manner, has created tremendous excitement in chemical biology and drug discovery within the past decades. The TPD field is spearheaded by small molecule induced protein degradation with molecular glues and proteolysis targeting chimeras (PROTACs) paving the way to expand the druggable space and to create a new paradigm in drug discovery. However, besides the therapeutic angle of TPD a plethora of novel techniques to modulate and control protein levels have been developed. This enables chemical biologists to better understand protein function and to discover and verify new therapeutic targets. This Review gives a comprehensive overview of chemical biology techniques inducing TPD. It explains the strengths and weaknesses of these methods in the context of drug discovery and discusses their future potential from a medicinal chemist's perspective.
引用
收藏
页码:15448 / 15466
页数:19
相关论文
共 17 条
  • [1] Targeted Protein Degradation: Principles and Applications of the Proteasome
    Kim, Yosup
    Kim, Eun-Kyung
    Chey, Yoona
    Song, Min-Jeong
    Jang, Ho Hee
    CELLS, 2023, 12 (14)
  • [2] Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway
    Collins, Ian
    Wang, Hannah
    Caldwell, John J.
    Chopra, Raj
    BIOCHEMICAL JOURNAL, 2017, 474 (07) : 1127 - 1147
  • [3] Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds
    Proschak, Ewgenij
    Stark, Holger
    Merk, Daniel
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (02) : 420 - 444
  • [4] A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery
    Barrow, James C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (05): : 687 - 689
  • [5] Targeted protein degradation for the treatment of Parkinson's disease: Advances and future perspective
    Amirian, Roshanak
    Badrbani, Mehdi Azadi
    Derakhshankhah, Hossein
    Izadi, Zhila
    Shahbazi, Mohammad-Ali
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 166
  • [6] Targeted degradation via direct 26S proteasome recruitment
    Bashore, Charlene
    Prakash, Sumit
    Johnson, Matthew C.
    Conrad, Ryan J.
    Kekessie, Ivy A.
    Scales, Suzie J.
    Ishisoko, Noriko
    Kleinheinz, Tracy
    Liu, Peter S.
    Popovych, Nataliya
    Wecksler, Aaron T.
    Zhou, Lijuan
    Tam, Christine
    Zilberleyb, Inna
    Srinivasan, Rajini
    Blake, Robert A.
    Song, Aimin
    Staben, Steven T.
    Zhang, Yingnan
    Arnott, David
    Fairbrother, Wayne J.
    Foster, Scott A.
    Wertz, Ingrid E.
    Ciferri, Claudio
    Dueber, Erin C.
    NATURE CHEMICAL BIOLOGY, 2023, 19 (01) : 55 - U30
  • [7] Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin-Proteasome system
    Xie, Hanshu
    Zhang, Chao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 267
  • [8] Expanding the horizons of targeted protein degradation: A non-small molecule perspective
    Huang, Xiaowei
    Wu, Fengbo
    Ye, Jing
    Wang, Lian
    Wang, Xiaoyun
    Li, Xiang
    He, Gu
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (06) : 2402 - 2427
  • [9] An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist's perspective
    Bakchi, Bulti
    Krishna, Ambati Dileep
    Sreecharan, Ekambarapu
    Ganesh, Veeramallu Bala Jaya
    Niharika, Muraboina
    Maharshi, Suryadevara
    Puttagunta, Srinivasa Babu
    Sigalapalli, Dilep Kumar
    Bhandare, Richie R.
    Shaik, Afzal B.
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1259
  • [10] Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions
    Kamaraj, Rajamanikkam
    Ghosh, Subhrojyoti
    Das, Souvadra
    Sen, Shinjini
    Kumar, Priyanka
    Majumdar, Madhurima
    Dasgupta, Renesa
    Mukherjee, Sampurna
    Das, Shrimanti
    Ghose, Indrilla
    Pavek, Petr
    Karuppiah, Muruga Poopathi Raja
    Chuturgoon, Anil A.
    Anand, Krishnan
    BIOCONJUGATE CHEMISTRY, 2024, 35 (08) : 1089 - 1115